Join Gregory Daniels, MD, PhD and Brian Hinds, MD from the University of California, San Diego as they present their expertise on a range of cases pertaining to melanoma.

Immunotherapy is emerging as a novel modality for controlling cancer and has been proposed as becoming the fourth cornerstone of cancer treatment along with surgery, radiotherapy, and chemotherapy.

Immunotherapy is emerging as a novel modality for controlling cancer and has been proposed as becoming the fourth cornerstone of cancer treatment along with surgery, radiotherapy, and chemotherapy.

Join Gregory Daniels, MD, PhD and Brian Hinds, MD from the University of California, San Diego as they present their expertise on a range of cases pertaining to melanoma.

The NCCN Guidelines for Melanoma have been significantly revised over the past few years in response to emerging data on a number of novel agents and treatment regimens.

This information was originally presented at the NCCN 21^st Annual Conference: Advancing the Standard of Cancer Care™ held in Hollywood, Florida, from March 31 – April 2, 2016.

This recorded webinar series is an educational program that addresses the health care professionals' need to be educated on current and emerging evidence-based scientific data for accurate and timely clinical evaluation of patients with melanoma and related skin cancers, management of both early-

This recorded webinar series is an educational program that addresses the health care professionals' need to be educated on current and emerging evidence-based scientific data for accurate and timely clinical evaluation of patients with melanoma and related skin cancers, management of both early-

This recorded webinar series is an educational program that addresses the health care professionals' need to be educated on current and emerging evidence-based scientific data for accurate and timely clinical evaluation of patients with melanoma and related skin cancers, management of both early-

This recorded webinar series is an educational program that addresses the health care professionals' need to be educated on current and emerging evidence-based scientific data for accurate and timely clinical evaluation of patients with melanoma and related skin cancers, management of both early-